WallStSmart

Afya Ltd (AFYA)vsStride Inc (LRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Afya Ltd generates 49% more annual revenue ($3.77B vs $2.54B). AFYA leads profitability with a 20.1% profit margin vs 12.1%. AFYA trades at a lower P/E of 8.5x. LRN earns a higher WallStSmart Score of 65/100 (B-).

AFYA

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 8.5Value: 8.3Quality: 5.8
Piotroski: 5/9

LRN

Strong Buy

65

out of 100

Grade: B-

Growth: 4.7Profit: 7.5Value: 6.7Quality: 8.5
Piotroski: 4/9Altman Z: 3.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AFYAUndervalued (+74.6%)

Margin of Safety

+74.6%

Fair Value

$61.03

Current Price

$14.44

$46.59 discount

UndervaluedFair: $61.03Overvalued
LRNOvervalued (-12.2%)

Margin of Safety

-12.2%

Fair Value

$87.11

Current Price

$101.96

$14.85 premium

UndervaluedFair: $87.11Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AFYA4 strengths · Avg: 9.8/10
P/E RatioValuation
8.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Operating MarginProfitability
38.9%10/10

Strong operational efficiency at 38.9%

Profit MarginProfitability
20.1%9/10

Keeps 20 of every $100 in revenue as profit

LRN5 strengths · Avg: 8.4/10
Altman Z-ScoreHealth
3.9210/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.558/10

Growing faster than its price suggests

P/E RatioValuation
15.3x8/10

Attractively priced relative to earnings

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.8%8/10

Strong operational efficiency at 20.8%

Areas to Watch

AFYA2 concerns · Avg: 3.5/10
EPS GrowthGrowth
3.2%4/10

3.2% earnings growth

Market CapQuality
$1.25B3/10

Smaller company, higher risk/reward

LRN2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

EPS GrowthGrowth
-4.5%2/10

Earnings declined 4.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : AFYA

The strongest argument for AFYA centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 38.9%.

Bull Case : LRN

The strongest argument for LRN centers on Altman Z-Score, PEG Ratio, P/E Ratio. PEG of 0.55 suggests the stock is reasonably priced for its growth.

Bear Case : AFYA

The primary concerns for AFYA are EPS Growth, Market Cap.

Bear Case : LRN

The primary concerns for LRN are Revenue Growth, EPS Growth.

Key Dynamics to Monitor

AFYA profiles as a mature stock while LRN is a value play — different risk/reward profiles.

AFYA carries more volatility with a beta of 0.39 — expect wider price swings.

AFYA is growing revenue faster at 8.2% — sustainability is the question.

AFYA generates stronger free cash flow (418M), providing more financial flexibility.

Bottom Line

LRN scores higher overall (65/100 vs 62/100). AFYA offers better value entry with a 74.6% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Afya Ltd

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Afya Limited, is a medical education group in Brazil. The company is headquartered in Nova Lima, Brazil.

Visit Website →

Stride Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Stride, Inc., a technology-based education company, provides its own and third-party online educational services, software systems and curricula to facilitate individualized learning for students primarily in kindergarten through grade 12 (K -12) in the United States and internationally. .

Visit Website →

Want to dig deeper into these stocks?